Patents by Inventor Hermann Alois Martin Mucke

Hermann Alois Martin Mucke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR THE DIAGNOSIS AND TREATMENT OF ESSENTIAL PRIMARY HYPERTENSION
    Publication number: 20230228764
    Abstract: The invention is in the field of molecular diagnosis of medical diseases and their treatment. More in particular, it provides methods and means for detecting hypertension, more in particular essential primary hypertension, even more in particular NOX5-dependent hypertension. The invention also provides methods for the treatment of hypertension, in particular essential primary hypertension, more in particular NOX5-dependent hypertension. The invention also provides theragnostics, wherein therapy is combined with diagnosis, more in particular wherein the level of NOX5 is determined in a sample from a subject and wherein the subject is treated with NOX5 inhibitors or compounds that decrease the levels of NOX5 if the NOX5 levels are above a certain threshold value.
    Type: Application
    Filed: May 21, 2021
    Publication date: July 20, 2023
    Applicants: Universiteit Maastricht, Academisch Ziekenhuis Maastricht
    Inventors: Harald Horst Heinz Wilhelm Schmidt, Mahmoud Hassan Mahmoud Elbatrik, Hermann Alois Martin Mucke
  • Method for the diagnosis and treatment of essential primary hypertension
    Patent number: 11480583
    Abstract: The invention is in the field of molecular diagnosis of medical diseases and their treatment. More in particular, it provides methods and means for detecting hypertension, more in particular essential primary hypertension, even more in particular NOX5-dependent hypertension. The invention also provides methods for the treatment of hypertension, in particular essential primary hypertension, more in particular NOX5-dependent hypertension. The invention also provides theragnostics, wherein therapy is combined with diagnosis, more in particular wherein the level of NOX5 is determined in a sample from a subject and wherein the subject is treated with NOX5 inhibitors or compounds that decrease the levels of NOX5 if the NOX5 levels are above a certain threshold value.
    Type: Grant
    Filed: December 16, 2021
    Date of Patent: October 25, 2022
    Assignees: Universitet Maastricht, Academisch Ziekenhuis Maastricht
    Inventors: Harald Horst Heinz Wilhelm Schmidt, Mahmoud Hassan Mahmoud Elbatrik, Hermann Alois Martin Mucke